Qiming Venture Partners
Room 3901, Jinmao Tower 88 Century Boulevard, Shanghai, 200121, China
Overview
Leading venture capital firm investing in technology and healthcare.
Founded
2006
Deals ยท 12mo
20
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
AusperBio | Aug 2026Participated | $120 MSeries C | |
Windward Bio | May 2026Participated | $165 MOther Equity | |
Vivacta Biotechnology (Shanghai) Co., Ltd. | Apr 2026Participated | $50 MSeries A | |
Pam Medical | Apr 2026Participated | $100 MSeries D | |
Pulnovo Medical | Apr 2026Participated | $100 MOther Equity | |
Oricell Therapeutics | Apr 2026Led | $110 MOther Equity | |
Syneron Bio | Apr 2026Participated | $150 MSeries B | |
StairMed | Apr 2026Participated | $73 MOther Equity | |
Immutrin | Mar 2026Participated | $87 MSeries A | |
CODE27 | Mar 2026Participated | $10 MSeed | |
ZhiTai Biotech | Mar 2026Participated | $73 MSeries C | |
QL Biopharma | Mar 2026Participated | $73 MSeries C | |
AusperBio | Aug 2026Participated | $120 MSeries C | |
Windward Bio | May 2026Participated | $165 MOther Equity | |
Vivacta Biotechnology (Shanghai) Co., Ltd. | Apr 2026Participated | $50 MSeries A | |
Pam Medical | Apr 2026Participated | $100 MSeries D | |
Pulnovo Medical | Apr 2026Participated | $100 MOther Equity | |
Oricell Therapeutics | Apr 2026Led | $110 MOther Equity | |
Syneron Bio | Apr 2026Participated | $150 MSeries B | |
StairMed | Apr 2026Participated | $73 MOther Equity | |
Immutrin | Mar 2026Participated | $87 MSeries A | |
CODE27 | Mar 2026Participated | $10 MSeed | |
ZhiTai Biotech | Mar 2026Participated | $73 MSeries C | |
QL Biopharma | Mar 2026Participated | $73 MSeries C |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 2 | 1 |
| Series A | 31 | 16 |
| Series B | 23 | 33 |
| Series C+ | 10 | 24 |
| Other Equity | 7 | 16 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jul '10 | 1 |
| Aug '10 | 2 |
| Sep '10 | 0 |
| Oct '10 | 0 |
| Nov '10 | 0 |
| Dec '10 | 0 |
| Jan '11 | 0 |
| Feb '11 | 0 |
| Mar '11 | 0 |
| Apr '11 | 0 |
| May '11 | 1 |
| Jun '11 | 0 |
| Jul '11 | 0 |
| Aug '11 | 1 |
| Sep '11 | 0 |
| Oct '11 | 0 |
| Nov '11 | 0 |
| Dec '11 | 1 |
| Jan '12 | 1 |
| Feb '12 | 0 |
| Mar '12 | 0 |
| Apr '12 | 1 |
| May '12 | 0 |
| Jun '12 | 0 |
| Jul '12 | 0 |
| Aug '12 | 0 |
| Sep '12 | 0 |
| Oct '12 | 0 |
| Nov '12 | 1 |
| Dec '12 | 0 |
| Jan '13 | 0 |
| Feb '13 | 0 |
| Mar '13 | 1 |
| Apr '13 | 0 |
| May '13 | 0 |
| Jun '13 | 0 |
| Jul '13 | 0 |
| Aug '13 | 1 |
| Sep '13 | 0 |
| Oct '13 | 0 |
| Nov '13 | 0 |
| Dec '13 | 0 |
| Jan '14 | 0 |
| Feb '14 | 1 |
| Mar '14 | 1 |
| Apr '14 | 1 |
| May '14 | 0 |
| Jun '14 | 2 |
| Jul '14 | 0 |
| Aug '14 | 1 |
| Sep '14 | 0 |
| Oct '14 | 0 |
| Nov '14 | 1 |
| Dec '14 | 1 |
| Jan '15 | 1 |
| Feb '15 | 0 |
| Mar '15 | 0 |
| Apr '15 | 0 |
| May '15 | 1 |
| Jun '15 | 0 |
| Jul '15 | 0 |
| Aug '15 | 1 |
| Sep '15 | 0 |
| Oct '15 | 0 |
| Nov '15 | 0 |
| Dec '15 | 0 |
| Jan '16 | 1 |
| Feb '16 | 0 |
| Mar '16 | 0 |
| Apr '16 | 0 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 0 |
| Aug '16 | 0 |
| Sep '16 | 0 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 1 |
| Jan '17 | 2 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 1 |
| Jun '17 | 0 |
| Jul '17 | 1 |
| Aug '17 | 1 |
| Sep '17 | 2 |
| Oct '17 | 1 |
| Nov '17 | 0 |
| Dec '17 | 1 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 2 |
| Apr '18 | 1 |
| May '18 | 1 |
| Jun '18 | 1 |
| Jul '18 | 1 |
| Aug '18 | 1 |
| Sep '18 | 0 |
| Oct '18 | 1 |
| Nov '18 | 3 |
| Dec '18 | 0 |
| Jan '19 | 2 |
| Feb '19 | 2 |
| Mar '19 | 1 |
| Apr '19 | 0 |
| May '19 | 2 |
| Jun '19 | 1 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 2 |
| Oct '19 | 2 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 2 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 1 |
| May '20 | 0 |
| Jun '20 | 1 |
| Jul '20 | 1 |
| Aug '20 | 3 |
| Sep '20 | 3 |
| Oct '20 | 0 |
| Nov '20 | 3 |
| Dec '20 | 2 |
| Jan '21 | 1 |
| Feb '21 | 1 |
| Mar '21 | 2 |
| Apr '21 | 0 |
| May '21 | 1 |
| Jun '21 | 3 |
| Jul '21 | 1 |
| Aug '21 | 5 |
| Sep '21 | 2 |
| Oct '21 | 1 |
| Nov '21 | 1 |
| Dec '21 | 0 |
| Jan '22 | 3 |
| Feb '22 | 3 |
| Mar '22 | 3 |
| Apr '22 | 1 |
| May '22 | 2 |
| Jun '22 | 1 |
| Jul '22 | 0 |
| Aug '22 | 5 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 1 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 3 |
| Apr '23 | 1 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 2 |
| Aug '23 | 2 |
| Sep '23 | 0 |
| Oct '23 | 1 |
| Nov '23 | 0 |
| Dec '23 | 3 |
| Jan '24 | 5 |
| Feb '24 | 1 |
| Mar '24 | 0 |
| Apr '24 | 2 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 2 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 1 |
| Jan '25 | 2 |
| Feb '25 | 0 |
| Mar '25 | 1 |
| Apr '25 | 0 |
| May '25 | 1 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 1 |
| Sep '25 | 2 |
| Oct '25 | 1 |
| Nov '25 | 1 |
| Dec '25 | 3 |
| Jan '26 | 2 |
| Feb '26 | 1 |
| Mar '26 | 4 |
| Apr '26 | 6 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 99 |
| Networks, Cloud & Communication | 28 |
| AI & Machine Learning | 19 |
| Manufacturing | 17 |
| Enterprise Software | 15 |
| Transportation & Logistics | 13 |
| Hardware & Robotics | 12 |
| Consumer & Lifestyle | 10 |
| Data, Analytics & IT | 8 |
| Space & Frontier Tech | 8 |
| Fintech | 8 |
| Clean Energy & Sustainability | 7 |
| Crypto & Blockchain | 7 |
| E-Commerce & Retail | 5 |
| Media & Entertainment | 5 |
| Social & Community Platforms | 4 |
| AR/VR | 3 |
| Travel & Hospitality | 2 |
| Education & Workforce | 2 |
| Cybersecurity & Privacy | 2 |
| Gaming & eSports | 2 |
| Professional Services | 2 |
| Real Estate & Construction | 1 |
| Marketing & Advertising | 1 |
| Food & Agriculture | 1 |
| Developer Tools | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 3 |
| $5M-$10M | 5 |
| $10M-$25M | 50 |
| $25M-$50M | 32 |
| $50M-$100M | 37 |
| $100M-$250M | 32 |
| $250M-$500M | 4 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 9 of 9 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| China | 103 |
| United States | 38 |
| Singapore | 8 |
| Europe | 5 |
| Indonesia | 2 |
| India | 2 |
| Hong Kong | 2 |
| Taiwan | 2 |
| Sunnyvale | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| OrbiMed | 18 |
| Lilly Asia Ventures | 14 |
| TF Capital | 13 |
| IDG Capital | 11 |
| Hongshan Capital Group (Sequoia Capital China) | 9 |
| Tencent | 8 |
| Legend Capital | 7 |
| Sinovation Ventures | 7 |
| Northern Light Venture Capital | 6 |
| Pavilion Capital | 6 |
| Quan Capital | 6 |
| Bold Capital Partners | 5 |
| CDH Investments | 5 |
| F-Prime Capital | 5 |
| 5Y Capital | 4 |
| Advantech Capital | 4 |
| B Capital Group | 4 |
| Deerfield Management | 4 |
| Eight Roads Ventures | 4 |
| Elikon Venture | 4 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 73 | 45% |
| Participating | 90 | 55% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 48 | 66% |
| Co-led | 25 | 34% |
Team
Partner
Venture Partner
Founding Managing Partner
Founder & Managing Partner
Partner & CFO
Partner
Principal
Managing Partner
Managing Partner